Vicarious Surgical (NYSE:RBOT – Free Report) had its target price cut by Piper Sandler from $12.00 to $10.50 in a research report report published on Wednesday morning,Benzinga reports. They currently have a neutral rating on the stock.
Vicarious Surgical Stock Performance
NYSE RBOT opened at $8.90 on Wednesday. Vicarious Surgical has a one year low of $4.27 and a one year high of $21.43. The company’s 50-day simple moving average is $6.89 and its two-hundred day simple moving average is $7.63. The company has a market capitalization of $52.51 million, a price-to-earnings ratio of -0.91 and a beta of 1.02.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported ($2.86) EPS for the quarter, topping the consensus estimate of ($2.98) by $0.12. Equities analysts expect that Vicarious Surgical will post -10.07 earnings per share for the current fiscal year.
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Further Reading
- Five stocks we like better than Vicarious Surgical
- Canada Bond Market Holiday: How to Invest and Trade
- Rocket Lab is the Right Stock for the Right Time
- What is a Low P/E Ratio and What Does it Tell Investors?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What Is WallStreetBets and What Stocks Are They Targeting?
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
